Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intralesional Bevacizumab Versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Keloids.

NCT07014280 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT07014280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07014280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intralesional Bevacizumab Versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Keloids.
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
July 1, 2025
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloids